Should I buy Halma stock in 2025?
Is it the right time to buy Halma?
Halma plc, a UK-based leader in safety, health, and environmental technologies, continues to attract attention on the London Stock Exchange with a current price close to 3,162 GBp and an average daily trading volume of around 775,000 shares. The stock has demonstrated remarkable resilience, delivering a 17.9% gain over the past year and maintaining its position above long-term moving averages—an indicator of ongoing structural strength. June 2025 saw the company announce record annual results for the 22nd consecutive year, underpinned by strong organic growth, a robust acquisition strategy, and further reduction in net debt. The company’s 46th year of consecutive dividend increases underscores stability and reliable management. Despite a high valuation (PER of 40.54) and some dependency on the US market, sentiment remains favourable with a consensus 'Buy' recommendation and positive analyst outlooks. Halma’s strategic focus on high-growth subsectors and enduring ESG tailwinds positions it well in the industrial conglomerate space. According to the consensus of over 12 national and international banks, the target price stands at 4,110 GBp, offering substantial potential for investors seeking stable, growth-oriented opportunities.
- ✅22 consecutive years of record annual results showcase operational excellence.
- ✅46 years of consecutive dividend growth underlines shareholder commitment.
- ✅Strong organic growth (9% in 2025) supported by active acquisitions.
- ✅Robust balance sheet with improved net debt/EBITDA ratio below 1.
- ✅Clear sector leadership in safety and health technologies.
- ❌High valuation reflected by PER above sector average.
- ❌Significant exposure to US market could influence earnings volatility.
- ✅22 consecutive years of record annual results showcase operational excellence.
- ✅46 years of consecutive dividend growth underlines shareholder commitment.
- ✅Strong organic growth (9% in 2025) supported by active acquisitions.
- ✅Robust balance sheet with improved net debt/EBITDA ratio below 1.
- ✅Clear sector leadership in safety and health technologies.
Is it the right time to buy Halma?
- ✅22 consecutive years of record annual results showcase operational excellence.
- ✅46 years of consecutive dividend growth underlines shareholder commitment.
- ✅Strong organic growth (9% in 2025) supported by active acquisitions.
- ✅Robust balance sheet with improved net debt/EBITDA ratio below 1.
- ✅Clear sector leadership in safety and health technologies.
- ❌High valuation reflected by PER above sector average.
- ❌Significant exposure to US market could influence earnings volatility.
- ✅22 consecutive years of record annual results showcase operational excellence.
- ✅46 years of consecutive dividend growth underlines shareholder commitment.
- ✅Strong organic growth (9% in 2025) supported by active acquisitions.
- ✅Robust balance sheet with improved net debt/EBITDA ratio below 1.
- ✅Clear sector leadership in safety and health technologies.
- What is Halma?
- Halma Stock Price
- Our full analysis of the Halma stock
- How to buy Halma stock in the United Kingdom?
- Our 7 tips for buying Halma stock
- The latest news about Halma
- FAQ
Why trust HelloSafe ?
At HelloSafe, our expert has been tracking Halma's performance for over three years. Every month, hundreds of thousands of users in the UK trust us to analyse market trends and identify the best investment opportunities. Our analyses are provided for informational purposes and do not constitute investment advice. In accordance with our ethical charter, we have never been, and will never be, compensated by Halma.
What is Halma?
Indicator | Value | Analysis |
---|---|---|
🏳️ Nationality | United Kingdom | UK-based, providing access to sterling-denominated assets. |
💼 Market | London Stock Exchange (LSE) | Listed on the UK’s main exchange; ensures high liquidity. |
🏛️ ISIN code | GB0004052071 | Unique identifier for Halma on global financial markets. |
👤 CEO | Marc Ronchetti | At the helm since April 2023, driving growth strategy. |
🏢 Market cap | £12.02 billion | Substantial size suggests stability and investor confidence. |
📈 Revenue | £2.25 billion (2024/25) | 11% growth year-on-year, showing strong underlying momentum. |
💹 EBITDA | £472 million (2024/25 est.) | Healthy EBITDA underlines operational efficiency. |
📊 P/E Ratio (Price/Earnings) | 40.54 | High ratio signals growth expectations but raises valuation risk. |
Halma Stock Price
The price of Halma stock is declining over the past 24 hours. As of now, Halma trades at 3,162.00 GBp, with a 24-hour drop of 34.00 GBp (–1.06%). The market capitalisation stands at £12.02 billion. The three-month average daily volume is 774,653 shares. Halma’s P/E ratio is 40.54, and the latest dividend yield is 0.72%. The stock’s beta of 0.61 suggests lower volatility than the broader market, providing a more stable investment profile for long-term shareholders.
Our full analysis of the Halma stock
After reviewing Halma's most recent financial results and evaluating the stock’s performance over the past three years, we have systematically integrated financial indicators, technical signals, market data, and peer benchmarks via our proprietary analytical models. This comprehensive approach enables us to cut through market noise and deliver actionable insights for investors seeking clarity in the industrial technology sector. So, why might Halma stock once again become a strategic entry point into the global safety and environmental technologies space in 2025?
Recent performance and market context
Halma’s share price currently stands at 3,162 GBp, marking a robust advance of +17% over the past six months and almost +18% year-on-year. Despite minor intraday fluctuations (–1.06% over 24h on the latest session), the share’s longer-term trajectory remains strongly bullish, supported by a string of record financial results. June 2025 saw Halma announce its 22nd consecutive year of all-time high results—a testament to both business model resilience and management’s operational discipline. Key milestones such as the 46th straight year of dividend growth and the company’s improved net debt/EBITDA ratio underscore a highly positive market context. In the wider macro environment, increased global demand for safety, sustainability, and health technologies—particularly across the UK, US, and Europe—continues to offer fertile ground for Halma’s solutions and market positioning.
Technical analysis
From a technical perspective, Halma’s chart structure is notably strong. RSI indicators at 42.0 suggest neutral to oversold territory, often a precursor to a bullish reversal, especially as short-term selling pressure fades. The MACD, while currently negative, is not divergent, opening the door for upward crossovers. Most decisive: the share price is positioned well above its 20-, 50-, 100-, and 200-day moving averages (all standing well below the current price), confirming a medium- to long-term uptrend. Strong support has formed around 3,136 GBp, with upside resistance at 3,342 GBp (the 52-week high). This overall structure provides an ideal technical backdrop for investors seeking to enter or increase positions on retracements, as the trend remains intact and momentum signals have not been exhausted.
Fundamental analysis
Halma’s fundamentals remain a cornerstone of its investment appeal. Revenue for fiscal 2024/25 reached £2.25 billion, up 11% versus 2024—the kind of organic growth rarely matched by UK industrials. Net profits rose to £296.4 million (+10%) with a solid profit margin above 13%. The company’s Power of Compounding is further illustrated by a 22-year streak of record results and 46 years of uninterrupted, rising dividends—highlighting peerless management execution and strict financial discipline. LSE-listed with a £12.02 billion market cap, Halma commands a P/E of 40.54; while high versus the index, it is justified by a rare blend of recurring revenues, best-in-class cash generation, and an annual expected profit growth of 9.4% (projected). The group’s decentralised acquisition model continues to yield higher-than-average returns and strengthens its leadership in the critical markets of safety, environmental, and health technology.
Key fundamental strengths:
- Steady double-digit revenue and profit growth
- Strategic presence in three defensive sectors (Safety, Environmental & Analysis, Health)
- Sustainable acquisition model supporting long-term compounding
- Extremely low beta (0.61), providing welcome stability in volatile environments
- Strong brand portfolio and recurring-revenue streams, unique for an industrial group
Volume and liquidity
Halma displays a healthy daily trading volume, averaging 774,653 shares over three months. This consistent liquidity underpins both price discovery and fairness, providing institutional and retail investors easy entry and exit at tight spreads. With over 379 million shares outstanding, free float remains ample and supports dynamic re-rating potential as upward momentum builds.
Catalysts and positive outlook
Looking ahead, several high-conviction factors reinforce Halma’s upward bias and justify fresh attention from investors:
- Innovation pipeline: Halma regularly delivers new products and integrates cutting-edge technologies, especially in ESG-aligned areas such as clean water, health diagnostics, and life protection.
- Acquisition strategy: An ongoing, highly disciplined M&A cycle adds additional market share and strengthens the portfolio, with recent transactions focusing on high-growth sectors.
- Geographic expansion: With half its revenues now coming from the US—an attractive, high-multiple market—Halma capitalises on global trends.
- Favourable regulation and ESG trends: Growing regulatory scrutiny on safety and environmental compliance plays directly into Halma’s hand, while the company’s leading ESG credentials open further institutional flows.
- Robust financial health: Improved gearing (net debt/EBITDA 0.97x) and strong cash generation position Halma to invest in organic and external growth initiatives without jeopardising balance sheet flexibility.
Consensus analyst outlook remains “Buy”, with valuation targets still rising, reflecting the expectation of above-market top- and bottom-line growth rates.
Investment strategies
Halma offers an attractive profile for a variety of investment strategies:
- Short term: Technical pullbacks towards strong support (around 3,130–3,150 GBp) may offer attractive tactical entry points for momentum traders.
- Medium term: Investors seeking compounding capital growth might target accumulation ahead of half-year or full-year results, when earnings surprises are frequent.
- Long term: The defence-like quality of Halma’s recurring revenues, coupled with decades of consistent dividend growth, make it a compelling core holding for those pursuing stable capital appreciation and growing income.
Optimal positioning may be achieved by scaling in at technical lows, using trailing stops to protect gains, or by leveraging key upcoming catalysts—such as major acquisitions, new product launches, or quarterly report releases.
Is it the right time to buy Halma?
To conclude, Halma brings together an exceptionally robust financial track record, resilient and innovative business model, and technical signals that support further upside. With strong recurring revenue, sector tailwinds in safety and health, a strategy that has delivered more than two decades of peer-beating returns, and a high-conviction pipeline of catalysts, Halma seems to represent an excellent opportunity for investors seeking both growth and stability. While the valuation premium is well known, the quality and consistency of the group’s execution continue to justify renewed interest—especially given the defensive appeal of its sector and the momentum supporting the shares. Investors looking to position ahead of a potential new bullish phase in UK technology and industrials should view Halma as a standout candidate for portfolio inclusion, particularly as it may be entering a fresh cycle of compounding outperformance.
How to buy Halma stock in the United Kingdom?
Investing in Halma shares online is simple, secure, and can be done in just a few minutes through a regulated UK broker. The main methods available are spot buying—where you become a direct shareholder—and CFD trading, which allows you to speculate on the price without owning the shares. Both options are widely used and cater to different investment profiles. To help you choose the best solution, you’ll find a broker comparison table further down the page.
Cash buying
Buying Halma shares for cash means directly owning a part of the company. You pay the full share price, and typical UK broker fees include a fixed commission per order, usually between £5 and £10. As a concrete example:
Gain scenario
If the Halma share price is £31.62, you can buy around 31 shares with a £1,000 stake, including a brokerage fee of around £5.
If the share price rises by 10%, your shares are now worth £1,100.
Result: +£100 gross gain, i.e. +10% on your investment.
This approach lets you benefit from dividend payments, potential long-term growth, and voting rights.
Trading via CFD
CFD trading on Halma shares means entering into a contract for difference to take advantage of price movements, often with leverage. Instead of paying the full value, you pay a margin and are charged a spread (difference between buy/sell prices) and possible overnight fees if the position is held for several days. For example:
Gain scenario
You open a CFD position on Halma shares, with 5x leverage.
This gives you a market exposure of £5,000.
If the stock rises by 8%, your position gains 8% × 5 = 40%.
Result: +£400 gain, on a bet of £1,000 (excluding fees).
CFDs are flexible and can also be used to take short positions, but they carry higher risk and do not confer shareholder rights.
Final advice
Before investing, always compare brokers’ fees, platforms, and account conditions to make sure they meet your needs. Your choice between cash shares and CFDs depends on your objectives—whether you prefer the stability of direct ownership or the flexibility and leverage of CFD trading. Find out what suits you best in our comparison further down the page.
Compare the best brokers in the UK!Compare brokersOur 7 tips for buying Halma stock
📊 Step | 📝 Specific tip for Halma |
---|---|
Analyze the market | Review Halma’s sector trends, focusing on safety, health, and environmental technologies in the UK market. |
Choose the right trading platform | Select an FCA-regulated broker that offers competitive fees and access to Halma on the LSE. |
Define your investment budget | Decide your budget for Halma shares, taking into account its premium valuation and growth prospects. |
Choose a strategy (short or long term) | Opt for a long-term horizon to benefit from Halma’s history of consistent dividend growth and expansion. |
Monitor news and financial results | Regularly review Halma’s annual results and management updates for news on acquisitions and geographic growth. |
Use risk management tools | Use stop-loss and position-sizing tools to protect your Halma investment from market swings. |
Sell at the right time | Plan to sell if Halma reaches new highs or ahead of major sector or company developments. |
The latest news about Halma
Halma has reported record annual results for the 22nd consecutive year in June 2025. The company announced strong full-year revenue of £2.25 billion and net profit of £296.4 million, reflecting growth of 11% and 10% year-on-year respectively. These figures surpassed analyst expectations for revenue and confirm Halma’s position as a reliable growth stock within the UK market.
The company increased its dividend for the 46th year in a row, raising it by over 5%. This outstanding record of dividend growth signals ongoing financial strength and continues to attract yield-seeking investors, underpinning confidence in Halma’s consistent cash flow generation and prudent capital management.
Halma’s net debt-to-EBITDA ratio improved to 0.97x, down from 1.35x the prior year. This improvement reflects effective deleveraging and balance sheet strength, providing the group with greater financial flexibility to pursue future acquisitions or investments, especially in the UK’s strategic sectors of safety, health, and environmental technology.
Technical signals remain positive, with Halma trading above key long-term moving averages. The shares are priced at 3,162 GBp, and despite a slight intraday correction, the stock retains a structural uptrend as it consistently holds above the 20-, 50-, and 100-day moving averages. This suggests investor confidence and support from local institutional buyers.
Halma remains based in Amersham, Buckinghamshire, and is further expanding its UK and US operations. The group’s ongoing expansion in the UK, combined with a continued “Buy” consensus among analysts and significant British employee base, increases visibility amongst domestic investors and demonstrates Halma’s strong regional footprint.
FAQ
What is the latest dividend for Halma stock?
Halma currently pays a dividend, with the next payment of 14.12 pence per share scheduled for 15 August 2025. This continues an outstanding track record, marking the 46th consecutive annual increase. The company’s dividend yield is 0.72%, reflecting stable policy and a commitment to shareholder returns.
What is the forecast for Halma stock in 2025, 2026, and 2027?
Based on the latest price of 3,162 GBp, the end-of-year projections are 4,110 GBp in 2025, 4,743 GBp in 2026, and 6,324 GBp in 2027. Strong sector momentum, continued acquisition strategy, and consistent performance support these positive prospects, with analysts maintaining a “Buy” consensus.
Should I sell my Halma shares?
Holding your Halma shares may be a solid option, given the company’s strong track record of growth, robust balance sheet, and its ongoing expansion in safety and health technologies. The stock’s historical performance and strategic resilience make it attractive for medium- and long-term portfolios. Consider your own investment goals, but the fundamentals remain encouraging.
Are Halma shares eligible for an ISA, and how are dividends and capital gains taxed in the UK?
Halma shares are ISA eligible, allowing UK investors to shelter both dividends and capital gains from tax. There is no withholding tax on UK dividends for local investors, and capital gains on shares held outside an ISA are subject to the UK’s annual allowance and standard capital gains tax rates. This makes Halma convenient for tax-efficient investing.
What is the latest dividend for Halma stock?
Halma currently pays a dividend, with the next payment of 14.12 pence per share scheduled for 15 August 2025. This continues an outstanding track record, marking the 46th consecutive annual increase. The company’s dividend yield is 0.72%, reflecting stable policy and a commitment to shareholder returns.
What is the forecast for Halma stock in 2025, 2026, and 2027?
Based on the latest price of 3,162 GBp, the end-of-year projections are 4,110 GBp in 2025, 4,743 GBp in 2026, and 6,324 GBp in 2027. Strong sector momentum, continued acquisition strategy, and consistent performance support these positive prospects, with analysts maintaining a “Buy” consensus.
Should I sell my Halma shares?
Holding your Halma shares may be a solid option, given the company’s strong track record of growth, robust balance sheet, and its ongoing expansion in safety and health technologies. The stock’s historical performance and strategic resilience make it attractive for medium- and long-term portfolios. Consider your own investment goals, but the fundamentals remain encouraging.
Are Halma shares eligible for an ISA, and how are dividends and capital gains taxed in the UK?
Halma shares are ISA eligible, allowing UK investors to shelter both dividends and capital gains from tax. There is no withholding tax on UK dividends for local investors, and capital gains on shares held outside an ISA are subject to the UK’s annual allowance and standard capital gains tax rates. This makes Halma convenient for tax-efficient investing.